By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

S1 BioPharma (Formerly Known As S1 Pharmaceuticals, Inc.) 

1 Independence Way, Suite 102

Jersey City  New Jersey  07305-5442  U.S.A.
Phone: 201-839-0941 Fax: 201-839-0942


SEARCH JOBS


Industry
Pharmaceutical






Company News
S1 BioPharma (Formerly Known As S1 Pharmaceuticals, Inc.) And Chong Kun Dang Pharmaceutical Corporation Announce Commercialization Agreement For Lorexys In South Korea For Treatment Of Hypoactive Sexual Desire Disorder (HSDD) In Women 12/8/2015 11:12:53 AM
Nicolas Sitchon, CEO Of S1 BioPharma (Formerly Known As S1 Pharmaceuticals, Inc.), To Present At BIO-Europe 2015 Conference 11/2/2015 7:43:38 AM
Dr. Robert Pyke From S1 BioPharma (Formerly Known As S1 Pharmaceuticals, Inc.) To Present At ExL Pharma CNS Clinical Trial Forum 11/2/2015 6:20:54 AM
S1 BioPharma (Formerly Known As S1 Pharmaceuticals, Inc.) Supports FDA Approval Of First-Ever Treatment For Hypoactive Sexual Desire Disorder 8/20/2015 6:47:56 AM
S1 BioPharma (Formerly Known As S1 Pharmaceuticals, Inc.) Supports FDA Advisory Committee's Recommendation To Approve The First-Ever Treatment For Hypoactive Sexual Desire Disorder 6/8/2015 7:23:55 AM
S1 BioPharma (Formerly Known As S1 Pharmaceuticals, Inc.) Prepares To Initiate Phase 2a Clinical Trial For Low Male Sexual Desire 3/3/2014 11:07:52 AM
S1 Pharmaceuticals, Inc. Doses First Patients in Phase 2a Clinical Trial of Lorexys in Premenopausal Women With HSDD 7/29/2013 9:20:35 AM
S1 Pharmaceuticals, Inc. Expands Focus to Include Male Sexual Health 5/14/2012 10:43:44 AM
S1 Pharmaceuticals, Inc. Announces New Executive Management and Scientific Advisory Board Appointments 4/24/2012 10:14:02 AM
S1 Pharmaceuticals, Inc. Announces New Executive Management and Scientific Advisory Board Appointments 3/8/2012 10:44:39 AM
12
//-->